Caption Management’s Halozyme HALO Stock Holding History

Caption Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,700	Closed	-$655K	–	1729
2024 Q4	$655K	Buy	+13,700	New	+$702K	0.01%	1019
2023 Q1	–	Sell	-27,500	Closed	-$1.56M	–	1269
2022 Q4	$1.56M	Hold	27,500	–	–	0.02%	621
2022 Q3	$1.09M	Buy	+27,500	New	+$1.22M	0.02%	840
2020 Q1	–	Sell	-53,500	Closed	-$1.02M	–	942
2019 Q4	$949K	Buy	53,500 +15,300	+40%	+$265K	0.03%	512
2019 Q3	$593K	Buy	+38,200	New	+$629K	0.03%	467

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's HALO Position: Q1 2025 in Review

Caption Management sold out of Halozyme (HALO) in Q1 2025, closing a stake of 13,700 shares — an estimated $655K sold.

Caption Management first reported a position in HALO in Q3 2019 and held it in 5 quarters. The position peaked at $1.56M in Q4 2022. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

Caption Management reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
Caption Management sold 13,700 Halozyme shares in Q1 2025, an estimated $655K.
Caption Management first reported a position in Halozyme in Q3 2019 and held it in 5 quarters.
Caption Management's Halozyme position peaked at $1.56M in Q4 2022.
550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.